Vertraagde tijd
Japan Exchange
04:28:34 10-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
156
JPY
|
-1,89%
|
|
+4,70%
|
-5,45%
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
101.628
|
70.754
|
16.537
|
12.300
|
14.331
|
-
|
-
|
Bedrijfswaarde
1 |
101.628
|
67.584
|
16.436
|
9.986
|
13.509
|
14.939
|
16.089
|
K/w-verhouding
|
-18,3
x
|
-13,7
x
|
-2,96
x
|
-2,93
x
|
-4,79
x
|
-5,59
x
|
-5,79
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
3.764
x
|
1.726
x
|
184
x
|
102
x
|
15,7
x
|
9,76
x
|
6,39
x
|
Bedrijfswaarde/omzet
|
3.764
x
|
1.648
x
|
183
x
|
82,5
x
|
14,8
x
|
10,2
x
|
7,17
x
|
Bedrijfswaarde/EBITDA
|
-
|
-
|
-3,43
x
|
-2,78
x
|
-15,5
x
|
-18
x
|
-32,2
x
|
Bedrijfswaarde/FCF
|
-23,6
x
|
-
|
-
|
-3,5
x
|
-2,31
x
|
-9,78
x
|
-5,86
x
|
FCF Yield
|
-4,24%
|
-
|
-
|
-28,5%
|
-43,3%
|
-10,2%
|
-17,1%
|
Price to Book
|
13
x
|
8,19
x
|
3,87
x
|
3,19
x
|
4,21
x
|
34,6
x
|
-8,55
x
|
Aantal aandelen (in duizenden)
|
51.666
|
55.148
|
61.704
|
74.543
|
90.130
|
-
|
-
|
Referentieprijs
2 |
1.967
|
1.283
|
268,0
|
165,0
|
159,0
|
159,0
|
159,0
|
Datum van publicatie
|
12/02/21
|
14/02/22
|
14/02/23
|
14/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
27
|
41
|
90
|
121
|
910
|
1.468
|
2.243
|
EBITDA
1 |
-
|
-
|
-4.793
|
-3.589
|
-869,5
|
-829,5
|
-500
|
Bedrijfsresultaat (EBIT)
1 |
-4.183
|
-5.384
|
-5.179
|
-3.379
|
-2.280
|
-2.102
|
-1.913
|
Operationele Marge
|
-15.492,59%
|
-13.131,71%
|
-5.754,44%
|
-2.792,56%
|
-250,55%
|
-143,16%
|
-85,3%
|
Resultaat voor belastingen (EBT)
1 |
-5.378
|
-4.462
|
-5.330
|
-3.626
|
-2.575
|
-2.304
|
-2.098
|
Nettowinst (verlies)
1 |
-5.512
|
-4.910
|
-5.169
|
-3.823
|
-2.579
|
-2.307
|
-2.172
|
Nettomarge
|
-20.414,81%
|
-11.975,61%
|
-5.743,33%
|
-3.159,5%
|
-283,37%
|
-157,14%
|
-96,83%
|
WPA
2 |
-107,2
|
-93,36
|
-90,67
|
-56,22
|
-33,18
|
-28,45
|
-27,45
|
Free Cash Flow
1 |
-4.307
|
-
|
-
|
-2.850
|
-5.853
|
-1.528
|
-2.745
|
FCF-marge
|
-15.951,85%
|
-
|
-
|
-2.355,37%
|
-643,19%
|
-104,06%
|
-122,38%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
12/02/21
|
14/02/22
|
14/02/23
|
14/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2020 S1
|
2021 S1
|
2021 Q3
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Omzet
1 |
14
|
20
|
10
|
11
|
11
|
22
|
8
|
60
|
7
|
101
|
108
|
6
|
-
|
360
|
350
|
-
|
500
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-1.849
|
-2.443
|
-1.429
|
-1.429
|
-1.635
|
-3.064
|
-1.041
|
-1.074
|
-888
|
-667
|
-1.555
|
-743
|
-1.081
|
-320
|
-300
|
-310
|
-310
|
Operationele Marge
|
-13.207,14%
|
-12.215%
|
-14.290%
|
-12.990,91%
|
-14.863,64%
|
-13.927,27%
|
-13.012,5%
|
-1.790%
|
-12.685,71%
|
-660,4%
|
-1.439,81%
|
-12.383,33%
|
-
|
-88,89%
|
-85,71%
|
-
|
-62%
|
Resultaat voor belastingen (EBT)
|
-2.624
|
-1.807
|
-1.868
|
-1.415
|
-
|
-3.213
|
-1.056
|
-
|
-735
|
-
|
-1.321
|
-709
|
-
|
-
|
-
|
-
|
-
|
Nettowinst (verlies)
|
-2.608
|
-1.892
|
-1.802
|
-1.460
|
-
|
-3.260
|
-696
|
-
|
-732
|
-
|
-1.392
|
-700
|
-
|
-
|
-
|
-
|
-
|
Nettomarge
|
-18.628,57%
|
-9.460%
|
-18.020%
|
-13.272,73%
|
-
|
-14.818,18%
|
-8.700%
|
-
|
-10.457,14%
|
-
|
-1.288,89%
|
-11.666,67%
|
-
|
-
|
-
|
-
|
-
|
WPA
2 |
-50,82
|
-36,60
|
-34,81
|
-26,48
|
-32,63
|
-59,11
|
-12,02
|
-19,54
|
-11,51
|
-10,37
|
-21,88
|
-9,910
|
-24,43
|
-4,960
|
-4,960
|
-4,960
|
-4,960
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
6/08/20
|
10/08/21
|
12/11/21
|
10/05/22
|
9/08/22
|
9/08/22
|
14/11/22
|
14/02/23
|
12/05/23
|
14/08/23
|
14/08/23
|
14/11/23
|
14/02/24
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
608
|
1.758
|
Nettokaspositie
1 |
-
|
3.170
|
101
|
2.314
|
822
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-0,733
x
|
-3,516
x
|
Free Cash Flow
1 |
-4.307
|
-
|
-
|
-2.850
|
-5.853
|
-1.528
|
-2.745
|
ROE (netto-inkomsten/eigen vermogen)
|
-54,6%
|
-59,6%
|
-79,4%
|
-92,8%
|
-123%
|
-170%
|
-
|
ROA (netto-inkomsten/totale activa)
|
-
|
-18,9%
|
-27,3%
|
-24%
|
-
|
-
|
-
|
Totale activa
1 |
-
|
25.938
|
18.913
|
15.914
|
-
|
-
|
-
|
Nettoactief per aandeel
2 |
152,0
|
157,0
|
69,30
|
51,70
|
37,80
|
4,600
|
-18,60
|
Cashflow per aandeel
2 |
-103,0
|
-88,40
|
-83,90
|
-52,90
|
-35,30
|
-31,60
|
-21,30
|
Capex
1 |
362
|
245
|
250
|
28
|
400
|
400
|
400
|
Capex/omzet
|
1.340,74%
|
597,56%
|
277,78%
|
23,14%
|
43,96%
|
27,24%
|
17,83%
|
Datum van publicatie
|
12/02/21
|
14/02/22
|
14/02/23
|
14/02/24
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
159
JPY Gemiddelde koersdoel
280
JPY Spread / Gemiddelde doel +76,10% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -5,45% | 92,11 mln. | | +2,97% | 108 mld. | | +10,21% | 105 mld. | | +1,57% | 23,46 mld. | | -12,77% | 21,72 mld. | | -7,05% | 18,64 mld. | | -37,64% | 17,45 mld. | | -6,50% | 17,19 mld. | | +6,00% | 13,99 mld. | | +37,20% | 12,53 mld. |
Biotherapeutische geneesmiddelen
|